Circulation, Vol 85, 1118-1124, Copyright © 1992 by American Heart Association
FL Belloni, J Wang and TH Hintze
BACKGROUND. In normal, conscious dogs, systemic injection of adenosine
causes arterial hypotension and a baroreceptor reflex tachycardia mediated
in part by withdrawal of vagal tone from the sinoatrial node. After vagal
section or muscarinic receptor blockade, however, adenosine injection
causes bradycardia via a direct sinoatrial node inhibition. Because cardiac
failure is marked by a loss of vagal tone, we hypothesized that adenosine
injection in dogs with failing hearts would reduce heart rate. METHODS AND
RESULTS. Mongrel dogs were instrumented with indwelling catheters,
manometers, and ventricular pacing electrodes. After the dogs had recovered
from the surgery, the ventricles were paced continuously at 210 beats per
minute for 3 weeks, followed by pacing at 240 beats per minute for an
additional week. This regimen caused mild ventricular and more striking
atrial hypertrophy and a gradual onset of physiological and clinical signs
of congestive heart failure. Adenosine injections that caused large
tachycardias before the pacing regimen began caused progressively smaller
increments in heart rate during the first 2 weeks of pacing. After 3 and 4
weeks, adenosine injections caused overt reductions in heart rate despite
the concomitant arterial depressor response. CONCLUSIONS. We conclude that
the loss of vagal tone associated with the development of cardiac failure
unmasks the direct negative chronotropic effect of exogenous adenosine on
the sinoatrial node.
ARTICLES
Adenosine causes bradycardia in pacing-induced cardiac failure
Department of Physiology, New York Medical College, Valhalla 10595.
This article has been cited by other articles:
![]() |
G. Zhao, A. Linke, X. Xu, M. Ochoa, F. Belloni, L. Belardinelli, and T. H. Hintze Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 182 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sun, A. Huang, G. Zhao, R. Bernstein, P. Forfia, X. Xu, A. Koller, G. Kaley, and T. H. Hintze Reduced NO-dependent arteriolar dilation during the development of cardiomyopathy Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H461 - H468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barankiewicz, A. M. Danks, E. Abushanab, L. Makings, T. Wiemann, R. A. Wallis, P. V. P. Pragnacharyulu, A. Fox, and P. J. Marangos Regulation of Adenosine Concentration and Cytoprotective Effects of Novel Reversible Adenosine Deaminase Inhibitors J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1230 - 1238. [Abstract] [Full Text] |
||||
![]() |
M. R. Kichuk, N. Seyedi, X. Zhang, C. C. Marboe, R. E. Michler, L. J. Addonizio, G. Kaley, A. Nasjletti, and T. H. Hintze Regulation of Nitric Oxide Production in Human Coronary Microvessels and the Contribution of Local Kinin Formation Circulation, July 1, 1996; 94(1): 44 - 51. [Abstract] [Full Text] |
||||
![]() |
C. J. Smith, D. Sun, C. Hoegler, B. S. Roth, X. Zhang, G. Zhao, X.-B. Xu, Y. Kobari, K. Pritchard Jr, W. C. Sessa, et al. Reduced Gene Expression of Vascular Endothelial NO Synthase and Cyclooxygenase-1 in Heart Failure Circ. Res., January 1, 1996; 78(1): 58 - 64. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |